Anzeige
Mehr »
Login
Freitag, 08.11.2024 Börsentäglich über 12.000 News von 674 internationalen Medien
4.000 Meilen, um herauszufinden, warum der „Warren Buffett des Bergbaus" in diese Kupferaktie investierte
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A2QGE6 | ISIN: US01749D1054 | Ticker-Symbol: 6V5
Tradegate
07.11.24
19:46 Uhr
20,800 Euro
+0,200
+0,97 %
Branche
Halbleiter
Aktienmarkt
S&P MidCap 400
1-Jahres-Chart
ALLEGRO MICROSYSTEMS INC Chart 1 Jahr
5-Tage-Chart
ALLEGRO MICROSYSTEMS INC 5-Tage-Chart
RealtimeGeldBriefZeit
20,20020,80007.11.
GlobeNewswire (Europe)
40 Leser
Artikel bewerten:
(0)

Allegro MicroSystems, Inc.: Allegro MicroSystems Reports Second Quarter 2025 Results

MANCHESTER, N.H., Oct. 31, 2024 (GLOBE NEWSWIRE) -- Allegro MicroSystems, Inc. ("Allegro" or the "Company") (Nasdaq: ALGM), a global leader in power and sensing semiconductor solutions for motion control and energy efficient systems, today announced financial results for its second quarter ended September 27, 2024.

"We delivered results in-line with our commitments. Second quarter sales were $187 million, with sequential growth in both Automotive and Industrial and Other end markets. Non-GAAP EPS was $0.08, at the high end of our outlook," said Vineet Nargolwala, President and CEO of Allegro. "We are encouraged by the continued demand for our differentiated solutions and the progress made by our customers and partners to rebalance their inventories. We continue to invest for growth to extend our market leadership. The accelerating pace of our new product introductions, as evidenced by our latest product releases, sets the stage for significant growth momentum in the near future."

Second Quarter Financial Highlights:

In thousands, except per share data Three-Month Period Ended Six-Month Period Ended
September 27,
2024
June 28,
2024
September 29,
2023
September 27,
2024
September 29,
2023
(Unaudited) (Unaudited) (Unaudited) (Unaudited) (Unaudited)
Net Sales
Automotive $141,893 $131,184 $197,321 $273,077 $382,751
Industrial and other 45,498 35,735 78,188 81,233 171,051
Total net sales $187,391 $166,919 $275,509 $354,310 $553,802
GAAP Financial Measures
Gross margin % 45.7% 44.8% 57.9% 45.3% 57.3%
Operating margin % 2.2% (6.4)% 26.5% (1.9)% 25.9%
Diluted EPS $(0.18) $(0.09) $0.34 $(0.27) $0.65
Non-GAAP Financial Measures
Gross margin % 48.8% 48.8% 58.3% 48.8% 58.1%
Operating margin % 11.7% 6.0% 31.3% 9.0% 31.0%
Diluted EPS $0.08 $0.03 $0.40 $0.11 $0.79

Business Outlook

For the third quarter of fiscal year 2025 ending December 27, 2024, the Company expects net sales to be in the range of $170 million to $180 million. This outlook comprehends continued progress toward vehicle electrification and ongoing inventory rebalancing as reflected in the latest third-party estimates, as well as typical December quarter seasonality. The Company also estimates the following results on a non-GAAP basis:

  • Gross Margin is expected to be between 49% and 51%,
  • The Company made a voluntary $25 million payment on its term loan facility on October 31, 2024 and now expects Interest Expense to be approximately $6 million, and
  • Diluted Earnings per Share are expected to be between $0.04 and $0.08.

Allegro has not provided a reconciliation of its third fiscal quarter outlook for non-GAAP Gross Margin, non-GAAP Interest Expense, and non-GAAP Diluted Earnings per Share because estimates of all of the reconciling items cannot be provided without unreasonable efforts. It is difficult to reasonably provide a forward-looking estimate between such forward-looking non-GAAP measures and the comparable forward-looking U.S. generally accepted accounting principles ("GAAP") measures. Certain factors that are materially significant to Allegro's ability to estimate these items are out of its control and/or cannot be reasonably predicted.

Earnings Webcast

A webcast will be held on Thursday, October 31, 2024 at 8:30 a.m., Eastern Time. Vineet Nargolwala, President and Chief Executive Officer, and Derek P. D'Antilio, Executive Vice President and Chief Financial Officer, will discuss Allegro's business and financial results.

The webcast will be available on the Investor Relations section of the Company's website at investors.allegromicro.com. A recording of the webcast will be posted in the same location shortly after the call concludes and will be available for at least 90 days.

About Allegro MicroSystems

Allegro MicroSystems is a leading global designer, developer, fabless manufacturer and marketer of sensor integrated circuits ("ICs") and application-specific analog power ICs enabling emerging technologies in the automotive and industrial markets. Allegro's diverse product portfolio provides efficient and reliable solutions for the electrification of vehicles, automotive ADAS safety features, automation for Industry 4.0 and power saving technologies for data centers and clean energy applications.

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. We intend such forward-looking statements to be covered by the safe harbor provisions for forward-looking statements contained in Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. All statements, other than statements of historical facts, contained in this press release including statements regarding our future results of operations and financial position, business strategy, prospective products and the plans and objectives of management for future operations, including, among others, statements regarding the liquidity, growth and profitability strategies and factors affecting our business are forward-looking statements. These statements involve known and unknown risks, uncertainties and other important factors that may cause our actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements.

Without limiting the foregoing, in some cases, you can identify forward-looking statements by terms such as "aim," "may," "will," "should," "expect," "exploring," "plan," "anticipate," "could," "intend," "target," "project," "would," "contemplate," "believe," "estimate," "predict," "potential," "seek," or "continue" or the negative of these terms or other similar expressions, although not all forward-looking statements contain these words. No forward-looking statement is a guarantee of future results, performance or achievements, and one should avoid placing undue reliance on such statements.

Forward-looking statements are based on our management's current expectations, beliefs and assumptions and on information currently available to us. Such beliefs and assumptions may or may not prove to be correct. Additionally, such forward-looking statements are subject to a number of known and unknown risks, uncertainties and assumptions, and actual results may differ materially from those expressed or implied in the forward-looking statements due to various factors, including, but not limited to, those identified in Part II, Item 7. "Management's Discussion and Analysis of Financial Condition and Results of Operations," and Part I, Item 1A. "Risk Factors" in our Annual Report on Form 10-K for the year ended March 29, 2024, as any such factors may be updated from time to time in our Quarterly Reports on Form 10-Q and our other filings with the Securities and Exchange Commission (the "SEC"). These risks and uncertainties include, but are not limited to: downturns or volatility in general economic conditions; our ability to compete effectively, expand our market share and increase our net sales and profitability; our reliance on a limited number of third-party semiconductor wafer fabrication facilities and suppliers of other materials; any failure to adjust purchase commitments and inventory management based on changing market conditions or customer demand; shifts in our product mix, customer mix or channel mix, which could negatively impact our gross margin; the cyclical nature of the semiconductor industry, including the analog segment in which we compete; any downturn or disruption in the automotive market or industry; our ability to successfully integrate the acquisition of other companies or technologies and products into our business; our ability to compensate for decreases in average selling prices of our products and increases in input costs; our ability to manage any sustained yield problems or other delays at our third-party wafer fabrication facilities or in the final assembly and test of our products; our ability to accurately predict our quarterly net sales and operating results and meet the expectations of investors; our dependence on manufacturing operations in the Philippines; our reliance on distributors to generate sales; events beyond our control impacting us, our key suppliers or our manufacturing partners; our ability to develop new product features or new products in a timely and cost-effective manner; our ability to manage growth; any slowdown in the growth of our end markets; the loss of one or more significant customers; our ability to meet customers' quality requirements; uncertainties related to the design win process and our ability to recover design and development expenses and to generate timely or sufficient net sales or margins; changes in government trade policies, including the imposition of export restrictions and tariffs; our exposures to warranty claims, product liability claims and product recalls; our dependence on international customers and operations; the availability of rebates, tax credits and other financial incentives on end-user demands for certain products; risks, liabilities, costs and obligations related to governmental regulations and other legal obligations, including export/trade control, privacy, data protection, information security, cybersecurity, consumer protection, environmental and occupational health and safety, antitrust, anti-corruption and anti-bribery, product safety, environmental protection, employment matters and tax; the volatility of currency exchange rates; our ability to raise capital to support our growth strategy; our indebtedness may limit our flexibility to operate our business; our ability to effectively manage our growth and to retain key and highly skilled personnel; our ability to protect our proprietary technology and inventions through patents or trade secrets; our ability to commercialize our products without infringing third-party intellectual property rights; disruptions or breaches of our information technology systems or confidential information or those of our third-party service providers; our principal stockholders has substantial control over us; anti-takeover provisions in our organizational documents and under the General Corporation Law of the State of Delaware; any failure to design, implement or maintain effective internal control over financial reporting; changes in tax rates or the adoption of new tax legislation; the negative impacts of sustained inflation on our business; the physical, transition and litigation risks presented by climate change; and other events beyond our control. Moreover, we operate in an evolving environment. New risk factors and uncertainties may emerge from time to time, and it is not possible for management to predict all risk factors and uncertainties.

You should read this press release and the documents that we reference completely and with the understanding that our actual future results may be materially different from what we expect. We qualify all of our forward-looking statements by these cautionary statements. All forward-looking statements speak only as of the date of this press release, and except as required by applicable law, we do not plan to publicly update or revise any forward-looking statements, whether as a result of any new information, future events, changed circumstances or otherwise.

This press release includes certain non-GAAP financial measures as defined by the SEC rules. These non-GAAP financial measures are provided in addition to, and not as a substitute for or superior to measures of, financial performance prepared in accordance with GAAP. There are a number of limitations related to the use of these non-GAAP financial measures versus their nearest GAAP equivalents. For example, other companies may calculate non-GAAP financial measures differently or may use other measures to evaluate their performance, all of which could reduce the usefulness of the presented non-GAAP financial measures as tools for comparison.

This press release may not be reproduced, forwarded to any person or published, in whole or in part.

ALLEGRO MICROSYSTEMS, INC.
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(in thousands, except share and per share amounts)
(Unaudited)
Three-Month Period Ended Six-Month Period Ended
September 27,
2024
September 29,
2023
September 27,
2024
September 29,
2023
Net sales $187,391 $275,509 $354,310 $553,802
Cost of goods sold 101,729 116,006 193,877 236,349
Gross profit 85,662 159,503 160,433 317,453
Operating expenses:
Research and development 43,510 43,428 88,714 86,403
Selling, general and administrative 38,085 43,160 78,282 87,389
Total operating expenses 81,595 86,588 166,996 173,792
Operating income (loss) 4,067 72,915 (6,563) 143,661
Interest and other (expense) income (12,398) 156 (18,341) (2,486)
Loss on change in fair value of forward repurchase contract (34,752) - (34,752) -
(Loss) income before income taxes (43,083) 73,071 (59,656) 141,175
Income tax (benefit) provision (9,470) 7,400 (8,430) 14,615
Net (loss) income (33,613) 65,671 (51,226) 126,560
Net income attributable to non-controlling interests 62 54 124 93
Net (loss) income attributable to Allegro MicroSystems, Inc. $(33,675) $65,617 $(51,350) $126,467
Net (loss) income per common share attributable to Allegro MicroSystems, Inc.:
Basic $(0.18) $0.34 $(0.27) $0.66
Diluted $(0.18) $0.34 $(0.27) $0.65
Weighted average shares outstanding:
Basic 189,182,850 192,431,094 191,324,281 192,214,210
Diluted 189,182,850 195,100,855 191,324,281 195,055,495

Supplemental Schedule of Total Net Sales

The following table summarizes total net sales by market within the Company's unaudited condensed consolidated statements of operations:

Three-Month Period Ended Change Six-Month Period Ended Change
September 27,
2024
September 29,
2023
Amount % September 27,
2024
September 29,
2023
Amount %
(Dollars in thousands) (Dollars in thousands)
Automotive $141,893 $197,321 $(55,428) (28)% $273,077 $382,751 $(109,674) (29)%
Industrial and other 45,498 78,188 (32,690) (42)% 81,233 171,051 (89,818) (53)%
Total net sales $187,391 $275,509 $(88,118) (32)% $354,310 $553,802 $(199,492) (36)%
ALLEGRO MICROSYSTEMS, INC.
CONDENSED CONSOLIDATED BALANCE SHEETS
(in thousands)
September 27,
2024
March 29,
2024
(Unaudited)
Assets
Current assets:
Cash and cash equivalents $188,751 $212,143
Restricted cash 10,287 10,018
Trade accounts receivable, net 76,985 118,508
Inventories 176,648 162,302
Prepaid income taxes 38,636 31,908
Prepaid expenses and other current assets 32,253 33,584
Current portion of related party notes receivable - 3,750
Total current assets 523,560 572,213
Property, plant and equipment, net 325,051 321,175
Deferred income tax assets 61,839 54,496
Goodwill 203,151 202,425
Intangible assets, net 266,753 276,854
Related party notes receivable, less current portion - 4,688
Equity investment in related party 30,186 26,727
Other assets 81,577 72,025
Total assets $1,492,117 $1,530,603
Liabilities, Non-Controlling Interests and Stockholders' Equity
Current liabilities:
Trade accounts payable $50,245 $35,964
Amounts due to related party 5,546 1,626
Accrued expenses and other current liabilities 62,742 76,389
Current portion of long-term debt 5,475 3,929
Total current liabilities 124,008 117,908
Long-term debt 396,056 249,611
Other long-term liabilities 33,345 31,368
Total liabilities 553,409 398,887
Commitments and contingencies
Stockholders' Equity:
Preferred stock - -
Common stock 1,840 1,932
Additional paid-in capital 993,988 694,332
(Accumulated deficit) retained earnings (31,931) 463,012
Accumulated other comprehensive loss (26,583) (28,841)
Equity attributable to Allegro MicroSystems, Inc. 937,314 1,130,435
Non-controlling interests 1,394 1,281
Total stockholders' equity 938,708 1,131,716
Total liabilities, non-controlling interests and stockholders' equity $1,492,117 $1,530,603
ALLEGRO MICROSYSTEMS, INC.
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(in thousands)
(Unaudited)
Three-Month Period Ended Six-Month Period Ended
September 27,
2024
September 29,
2023
September 27,
2024
September 29,
2023
Cash flows from operating activities:
Net (loss) income $(33,613) $65,671 $(51,226) $126,560
Adjustments to reconcile net (loss) income to net cash provided by operating activities:
Depreciation and amortization 15,997 15,080 32,455 29,353
Amortization of deferred financing costs 306 73 1,087 107
Deferred income taxes (2,796) (9,772) (7,795) (18,134)
Stock-based compensation 11,545 10,877 21,663 21,919
Loss on change in fair value of forward repurchase contract 34,752 - 34,752 -
Provisions for inventory and expected credit losses 2,111 4,239 4,488 9,422
Change in fair value of marketable securities - (72) - 3,579
Other non-cash reconciling items 6,563 43 6,577 43
Changes in operating assets and liabilities:
Trade accounts receivable (13,717) 2,676 41,417 (7,645)
Inventories (2,845) (3,274) (18,831) (31,221)
Prepaid expenses and other assets (14,093) (6,253) (15,808) (16,453)
Trade accounts payable 13,470 (15,736) 13,670 2,695
Due to and from related parties 695 (3,990) 4,132 6,112
Accrued expenses and other current and long-term liabilities (2,828) (12,832) (16,838) (29,944)
Net cash provided by operating activities 15,547 46,730 49,743 96,393
Cash flows from investing activities:
Purchases of property, plant and equipment (9,972) (31,191) (20,949) (76,101)
Sales of marketable securities - 6,204 - 16,175
Net cash used in investing activities (9,972) (24,987) (20,949) (59,926)
Cash flows from financing activities:
Loan made to affiliate - (4,000) - (4,000)
Net proceeds from Refinanced 2023 Term Loan Facility 193,483 - 193,483 -
Payment of borrowings under 2023 Term Loan Facility - - (50,000) -
Finance lease payments (240) - (385) -
Receipts on related party notes receivable 937 937 1,875 1,875
Payments for taxes related to net share settlement of equity awards (1,126) (1,669) (12,297) (14,091)
Proceeds from issuance of common stock under employee stock purchase plan 1,987 - 1,987 1,899
Repurchases of common stock (853,805) - (853,805) -
Net proceeds from issuance of common stock 665,850 - 665,850 -
Payment of debt issuance costs - - - (1,450)
Net cash provided by (used in) financing activities 7,086 (4,732) (53,292) (15,767)
Effect of exchange rate changes on cash and cash equivalents and restricted cash 2,200 (901) 1,375 (974)
Net increase (decrease) in cash and cash equivalents and restricted cash 14,861 16,110 (23,123) 19,726
Cash and cash equivalents and restricted cash at beginning of period 184,177 362,321 222,161 358,705
Cash and cash equivalents and restricted cash at end of period: $199,038 $378,431 $199,038 $378,431

Non-GAAP Financial Measures

In addition to the measures presented in our condensed consolidated financial statements, we regularly review other measures, defined as non-GAAP Financial Measures by the SEC, to evaluate our business, measure our performance, identify trends, prepare financial forecasts and make strategic decisions. The key measures we consider are non-GAAP Gross Profit, non-GAAP Gross Margin, non-GAAP Operating Expenses, non-GAAP Operating Income, non-GAAP Operating Margin, EBITDA, Adjusted EBITDA, Adjusted EBITDA margin, non-GAAP Profit before Tax, non-GAAP Income Tax Provision, non-GAAP Effective Tax Rate, non-GAAP Net Income Attributable to Allegro MicroSystems, Inc, non-GAAP Basic and Diluted Earnings per Share, non-GAAP Free Cash Flow, and non-GAAP Free Cash Flow as percentage of net sales (collectively, the "Non-GAAP Financial Measures"). These Non-GAAP Financial Measures provide supplemental information regarding our operating performance on a non-GAAP basis that excludes certain gains, losses and charges of a non-cash nature or that occur relatively infrequently and/or that management considers to be unrelated to our core operations, and in the case of non-GAAP Income Tax Provision, management believes that this non-GAAP measure of income taxes provides it with the ability to evaluate the non-GAAP Income Tax Provision across different reporting periods on a consistent basis, independent of special items and discrete items, which may vary in size and frequency. These Non-GAAP Financial Measures are used by both management and our board of directors, together with the comparable GAAP information, in evaluating our current performance and planning our future business activities.

The Non-GAAP Financial Measures are supplemental measures of our performance that are neither required by, nor presented in accordance with, GAAP. These Non-GAAP Financial Measures should not be considered as substitutes for GAAP Financial Measures, such as gross profit, gross margin, net income or any other performance measures derived in accordance with GAAP. Also, in the future we may incur expenses or charges, such as those being adjusted in the calculation of these Non-GAAP Financial Measures. Our presentation of these Non-GAAP Financial Measures should not be construed as an inference that future results will be unaffected by unusual or nonrecurring items. These Non-GAAP Financial Measures exclude costs related to acquisition and related integration expenses, amortization of acquired intangible assets, stock-based compensation, restructuring actions, related party activities and other non-operational costs.

Non-GAAP Income Tax Provision

In calculating non-GAAP Income Tax Provision, we have added back the following to GAAP Income Tax Provision:

  • Tax effect of adjustments to GAAP results-Represents the estimated income tax effect of the adjustments to non-GAAP Profit before Tax described below and elimination of discrete tax adjustments.
Reconciliation of Non-GAAP Gross Profit and Non-GAAP Gross Margin
Three-Month Period Ended Six-Month Period Ended
September 27,
2024
June 28,
2024
September 29,
2023
September 27,
2024
September 29,
2023
(Dollars in thousands) (Dollars in thousands)
GAAP Gross Profit $85,662 $74,771 $159,503 $160,433 $317,453
GAAP Gross Margin (% of net sales) 45.7% 44.8% 57.9% 45.3% 57.3%
Non-GAAP adjustments
Transaction-related costs 10 (1) - 9 -
Purchased intangible amortization 4,875 4,875 273 9,750 675
Restructuring costs 16 1,200 - 1,216 -
Stock-based compensation 817 561 946 1,378 3,552
Total Non-GAAP Adjustments $5,718 $6,635 $1,219 $12,353 $4,227
Non-GAAP Gross Profit $91,380 $81,406 $160,722 $172,786 $321,680
Non-GAAP Gross Margin (% of net sales) 48.8% 48.8% 58.3% 48.8% 58.1%
Reconciliation of Non-GAAP Operating Expenses
Three-Month Period Ended Six-Month Period Ended
September 27,
2024
June 28,
2024
September 29,
2023
September 27,
2024
September 29,
2023
(Dollars in thousands) (Dollars in thousands)
GAAP Operating Expenses $81,595 $85,401 $86,588 $166,996 $173,792
Research and Development Expenses
GAAP Research and Development Expenses 43,510 45,204 43,428 88,714 86,403
Non-GAAP adjustments
Transaction-related costs 206 1,029 2 1,235 9
Restructuring costs 260 169 - 429 -
Stock-based compensation 3,523 3,735 3,602 7,258 6,470
Other costs(1) 3 - - 3 -
Non-GAAP Research and Development Expenses 39,518 40,271 39,824 79,789 79,924
Selling, General and Administrative Expenses
GAAP Selling, General and Administrative Expenses 38,085 40,197 43,160 78,282 87,389
Non-GAAP adjustments
Transaction-related costs 275 814 1,804 1,089 4,876
Purchased intangible amortization 535 535 357 1,070 715
Restructuring costs 2,046 1,045 - 3,091 -
Stock-based compensation 7,205 5,822 6,329 13,027 11,897
Other costs(1) (1,820) 811 100 (1,009) 100
Non-GAAP Selling, General and Administrative Expenses 29,844 31,170 34,570 61,014 69,801
Total Non-GAAP Adjustments 12,233 13,960 12,194 26,193 24,067
Non-GAAP Operating Expenses $69,362 $71,441 $74,394 $140,803 $149,725
(1) Included in non-GAAP other costs are non-recurring charges that are individually immaterial for separate disclosure, such as project evaluation costs, which consist of costs and estimated costs incurred in connection with debt and equity financings or other non-recurring transactions.
Reconciliation of Non-GAAP Operating Income and Non-GAAP Operating Margin
Three-Month Period Ended Six-Month Period Ended
September 27,
2024
June 28,
2024
September 29,
2023
September 27,
2024
September 29,
2023
(Dollars in thousands) (Dollars in thousands)
GAAP Operating Income (Loss) $4,067 $(10,630) $72,915 $(6,563) $143,661
GAAP Operating Margin (% of net sales) 2.2% (6.4)% 26.5% (1.9)% 25.9%
Transaction-related costs 491 1,842 1,806 2,333 4,885
Purchased intangible amortization 5,410 5,410 630 10,820 1,390
Restructuring costs 2,322 2,414 - 4,736 -
Stock-based compensation 11,545 10,118 10,877 21,663 21,919
Other costs(1) (1,817) 811 100 (1,006) 100
Total Non-GAAP Adjustments $17,951 $20,595 $13,413 $38,546 $28,294
Non-GAAP Operating Income $22,018 $9,965 $86,328 $31,983 $171,955
Non-GAAP Operating Margin (% of net sales) 11.7% 6.0% 31.3% 9.0% 31.0%
(1) Included in non-GAAP other costs are non-recurring charges that are individually immaterial for separate disclosure such as project evaluation costs, which consist of costs and estimated costs incurred in connection with debt and equity financings or other non-recurring transactions.
Reconciliation of EBITDA and Adjusted EBITDA
Three-Month Period Ended Six-Month Period Ended
September 27,
2024
June 28,
2024
September 29,
2023
September 27,
2024
September 29,
2023
(Dollars in thousands) (Dollars in thousands)
GAAP Net (Loss) Income $(33,613) $(17,613) $65,671 $(51,226) $126,560
GAAP Net (Loss) Income Margin (% of net sales) (17.9)% (10.6)% 23.8% (14.5)% 22.9%
Interest expense 10,353 5,377 758 15,730 1,527
Interest income (420) (494) (850) (914) (1,693)
Income tax (benefit) provision (9,470) 1,040 7,400 (8,430) 14,615
Depreciation & amortization 15,997 16,458 15,145 32,455 29,418
EBITDA $(17,153) $4,768 $88,124 $(12,385) $170,427
Transaction-related costs 3,295 1,842 1,806 5,137 4,885
Restructuring costs 2,067 2,414 - 4,481 -
Stock-based compensation 11,545 10,118 10,877 21,663 21,919
Loss on change in fair value of forward repurchase contract 34,752 - - 34,752 -
Other costs(1) (2,195) 2,807 1,301 612 5,890
Adjusted EBITDA $32,311 $21,949 $102,108 $54,260 $203,121
Adjusted EBITDA Margin (% of net sales) 17.2% 13.1% 37.1% 15.3% 36.7%
(1) Included in non-GAAP other costs are non-recurring charges that are individually immaterial for separate disclosure such as project evaluation costs, which consist of costs and estimated costs incurred in connection with debt and equity financings or other non-recurring transactions and income (loss) in earnings of equity investments.
Reconciliation of Non-GAAP Profit before Tax
Three-Month Period Ended Six-Month Period Ended
September 27,
2024
June 28,
2024
September 29,
2023
September 27,
2024
September 29,
2023
(Dollars in thousands) (Dollars in thousands)
GAAP (Loss) Income before Income Taxes $(43,083) $(16,573) $73,071 $(59,656) $141,175
Transaction-related costs 3,295 1,842 1,806 5,137 4,885
Transaction-related interest 141 709 - 850 -
Purchased intangible amortization 5,410 5,410 630 10,820 1,390
Restructuring costs 2,067 2,414 - 4,481 -
Stock-based compensation 11,545 10,118 10,877 21,663 21,919
Loss on change in fair value of forward repurchase contract 34,752 - - 34,752 -
Other costs(1) 1,428 2,807 1,301 4,235 5,890
Total Non-GAAP Adjustments $58,638 $23,300 $14,614 $81,938 $34,084
Non-GAAP Profit before Tax $15,555 $6,727 $87,685 $22,282 $175,259
(1) Included in non-GAAP other costs are non-recurring charges that are individually immaterial for separate disclosure such as project evaluation costs, which consist of costs and estimated costs incurred in connection with debt and equity financings or other non-recurring transactions and income (loss) in earnings of equity investments.
Reconciliation of Non-GAAP Income Tax Provision and Non-GAAP Effective Tax Rate
Three-Month Period Ended Six-Month Period Ended
September 27,
2024
June 28,
2024
September 29,
2023
September 27,
2024
September 29,
2023
(Dollars in thousands) (Dollars in thousands)
GAAP Income Tax (Benefit) Provision $(9,470) $1,040 $7,400 $(8,430) $14,615
GAAP effective tax rate 22.0% (6.3)% 10.1% 14.1% 10.4%
Tax effect of adjustments to GAAP results 10,071 (395) 2,554 9,676 6,380
Non-GAAP Income Tax Provision $601 $645 $9,954 $1,246 $20,995
Non-GAAP effective tax rate 3.9% 9.6% 11.4% 5.6% 12.0%
Reconciliation of Non-GAAP Net Income Attributable to Allegro MicroSystems, Inc. and Non-GAAP Earnings per Share
Three-Month Period Ended Six-Month Period Ended
September 27,
2024
June 28,
2024
September 29,
2023
September 27,
2024
September 29,
2023
(Dollars in thousands) (Dollars in thousands)
GAAP Net (Loss) Income Attributable to Allegro MicroSystems, Inc.(1) $(33,675) $(17,675) $65,617 $(51,350) $126,467
GAAP Basic weighted average common shares 189,182,850 193,465,708 192,431,094 191,324,281 192,214,210
GAAP Diluted weighted average common shares 189,182,850 193,465,708 195,100,855 191,324,281 195,055,495
GAAP Basic (Loss) Earnings per Share $(0.18) $(0.09) $0.34 $(0.27) $0.66
GAAP Diluted (Loss) Earnings per Share $(0.18) $(0.09) $0.34 $(0.27) $0.65
Transaction-related costs 3,295 1,842 1,806 5,137 4,885
Transaction-related interest 141 709 - 850 -
Purchased intangible amortization 5,410 5,410 630 10,820 1,390
Restructuring costs 2,067 2,414 - 4,481 -
Stock-based compensation 11,545 10,118 10,877 21,663 21,919
Loss on change in fair value of forward repurchase contract 34,752 - - 34,752 -
Other costs(2) 1,428 2,807 1,301 4,235 5,890
Total Non-GAAP Adjustments 58,638 23,300 14,614 81,938 34,084
Tax effect of adjustments to GAAP results(3) (10,071) 395 (2,554) (9,676) (6,380)
Non-GAAP Net Income Attributable to Allegro MicroSystems, Inc. $14,892 $6,020 $77,677 $20,912 $154,171
Basic weighted average common shares 189,182,850 193,465,708 192,431,094 191,324,281 192,214,210
Diluted weighted average common shares 189,710,595 194,705,716 195,100,855 192,154,185 195,055,495
Non-GAAP Basic Earnings per Share $0.08 $0.03 $0.40 $0.11 $0.80
Non-GAAP Diluted Earnings per Share $0.08 $0.03 $0.40 $0.11 $0.79
(1) GAAP Net (Loss) Income Attributable to Allegro MicroSystems, Inc. represents GAAP Net (Loss) Income adjusted for Net Income Attributable to non-controlling interests.
(2) Included in non-GAAP other costs are non-recurring charges that are individually immaterial for separate disclosure, such as project evaluation costs, which consists of costs and estimated costs incurred in connection with debt and equity financings or other non-recurring transactions, income (loss) in earnings of equity investments, and unrealized losses (gains) on investments.
(3) To calculate the tax effect of adjustments to GAAP results, the Company considers each Non-GAAP adjustment by tax jurisdiction and reverses all discrete items to calculate an annual Non-GAAP effective tax rate ("NG ETR"). This NG ETR is then applied to Non-GAAP Profit Before Tax to arrive at the tax effect of adjustments to GAAP results.
Reconciliation of Non-GAAP Free Cash Flow and Non-GAAP Free Cash Flow as Percentage of Net Sales
Three-Month Period Ended Six-Month Period Ended
September 27,
2024
June 28,
2024
September 29,
2023
September 27,
2024
September 29,
2023
(Dollars in thousands) (Dollars in thousands)
GAAP Operating Cash Flow $15,547 $34,196 $46,730 $49,743 $96,393
GAAP Operating Cash Flow (% of net sales) 8.3% 20.5% 17.0% 14.0% 17.4%
Non-GAAP adjustments
Purchases of property, plant and equipment (9,972) (10,977) (31,191) (20,949) (76,101)
Non-GAAP Free Cash Flow $5,575 $23,219 $15,539 $28,794 $20,292
Non-GAAP Free Cash Flow (% of net sales) 3.0% 13.9% 5.6% 8.1% 3.7%

Investor Contact:
Jalene Hoover
VP of Investor Relations & Corporate Communications
+1 (512) 751-6526
jhoover@allegromicro.com


© 2024 GlobeNewswire (Europe)
Tenbagger-Chance mit der nächsten BioNTech

Erinnern Sie sich, als Moderna und BioNTech von unbekannten Unternehmen zu globalen Marktführern wurden und frühzeitige Investoren reich belohnt haben?

Die Branche steht vor einem erneuten Innovationsschub – von bahnbrechenden Medikamenten bis hin zu revolutionären Therapien.

Warum sollten Sie dabei sein?

Sie sollten jetzt in Biotech-Aktien einsteigen, weil wir am Beginn einer neuen Ära der medizinischen Innovation stehen könnten! Gen- und Zelltherapien, personalisierte Medizin und bahnbrechende Technologien könnten das Gesundheitswesen revolutionieren – und die Aktienkurse in die Höhe schießen lassen.

Die nächste Erfolgsgeschichte im Biotechbereich warten nur darauf, entdeckt zu werden. Wer jetzt investiert, hat die Chance, von gigantischen Durchbrüchen und enormen Renditen zu profitieren. Warten Sie nicht, bis es zu spät ist - der nächste Biotech-Superstar könnte morgen schon durchstarten!

Verpassen Sie nicht diese Chance!

Fordern Sie sofort unseren brandneuen Biotech-Spezialreport an und erfahren Sie, welche 3 Biotech-Aktien das riesige Potenzial haben, Ihren finanziellen Erfolg zu sichern. Dieser Report ist komplett kostenlos und zeigt Ihnen zukunftsträchtige Investments im Biotech-Sektor.

Handeln Sie jetzt und sichern Sie sich Ihren kostenfreien Report!

Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.